KRAS and familial pancreatic carcinoma: Moreover, analysis of human TCGA data demonstrated that loss of these specific SNARES, but not other SNARE family members, was associated with improved clinical survival in KRAS mutant pancreatic cancer, suggesting that oncogenic KRAS depends upon intactness of these SNAREs to achieve its full malignant impacts.